Calmare Therapeutics Current Ratio vs. Revenue
| CTTCDelisted Stock | USD 0.0001 0.00 0.00% |
For Calmare Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Calmare Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Calmare Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Calmare Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Calmare Therapeutics over time as well as its relative position and ranking within its peers.
Calmare |
Calmare Therapeutics Revenue vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Calmare Therapeutics's current stock value. Our valuation model uses many indicators to compare Calmare Therapeutics value to that of its competitors to determine the firm's financial worth. Calmare Therapeutics is rated third in current ratio category among its peers. It is the top company in revenue category among its peers totaling about 5,313,073 of Revenue per Current Ratio. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Calmare Therapeutics' earnings, one of the primary drivers of an investment's value.Calmare Revenue vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Calmare Therapeutics |
| = | 0.22 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Calmare Therapeutics |
| = | 1.17 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Calmare Revenue vs Competition
Calmare Therapeutics is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 49.6 Billion. Calmare Therapeutics adds roughly 1.17 Million in revenue claiming only tiny portion of equities under Health Care industry.
Calmare Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Calmare Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Calmare Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Calmare Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Calmare Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut. Calmare Therapeutics operates under Medical Devices classification in the United States and is traded on NYSEMKT Exchange. It employs 7 people.
Calmare Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Calmare Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Calmare Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Calmare Therapeutics' important profitability drivers and their relationship over time.
Use Calmare Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Calmare Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calmare Therapeutics will appreciate offsetting losses from the drop in the long position's value.Calmare Therapeutics Pair Trading
Calmare Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Calmare Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Calmare Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Calmare Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Calmare Therapeutics to buy it.
The correlation of Calmare Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Calmare Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Calmare Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Calmare Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Calmare Therapeutics position
In addition to having Calmare Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run ISP Thematic Idea Now
ISP
Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. The ISP theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ISP Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Calmare Stock
If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |